FDANonrulemakingFDA-2017-D-0154

Who commented on this docket

Considerations in Demonstrating Interchangeability With a Reference Product

3 organizations filed 3 public comments on Considerations in Demonstrating Interchangeability With a Reference Product, at the Food and Drug Administration. The comment window closed 707d ago.

Organizations
3
Comments
3
RIN
Comment window
closed 707d ago

Commenters (3)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.